Latest Heartfelt Technologies News & Updates
See the latest news and media coverage for Heartfelt Technologies. We track all announcements, press releases, and industry mentions in real time, all in one place.
AI-powered non-contact telemonitoring for heart failure patients
hftech.org- Headquarters
- Cambridge, United Kingdom
- Founded year
- 2015
- Company type
- Private company
- Number of employees
- 25–50
Latest news about Heartfelt Technologies
Company announcements
-
Heartfelt Technologies celebrates FOOT Study publication
The study shows the Heartfelt Device detects heart failure changes up to 13 days in advance. It thanks NHS collaborators.
-
Heartfelt Technologies announces first U.S. installation
The installation supports the FDA-approved HEARTFELT Study for 1,600 patients, with remote monitoring by Connect America at The Heart Center CT.
-
Heartfelt Technologies announces UK pilot success
The pilot demonstrates reliable AI-enabled monitoring for heart failure patients in community settings, reducing readmission risks without added burden. The team seeks US research partners at HFSA ASM2025.
-
Heartfelt Technologies announces new clinical trials
An Innovate UK-funded trial is underway. An NIHR-backed study begins recruiting this summer in the UK. An FDA IDE-B approved trial starts in the US in late summer/early autumn 2025.
Media coverage
-
HeartSciences Reminds Its Shareholders to Submit Their Vote at the Upcoming April 30, 2026, Annual Shareholders Meeting
Southlake, TX, April 14, 2026 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”) a healthcare information...
-
Digital twin hearts deliver 100% success in arrhythmia trial | Hub
Novel technology outperforms clinical standard for life-threatening condition...
-
Evaluating Heartfelt’s predictive utility in heart failure: insights from the FOOT multicentre trial | BMJ Innovations
The advent of remote monitoring ... of these technologies is their reliance on consistent patient adherence to measurements and/or data transmission, which may impact their...
-
Artificial Intelligence Meets Real-World Heart Failure: Early Results from the HF-TRACK Trial
Optimal Mean Arterial Pressure, Time in Target Range, and Outcomes in HeartMate 3 Recipients: Pooled Individual-Patient Data from MOMENTUM-3 and ARIES-HM3 Trials Receive the the...
Track Heartfelt Technologies and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Trending companies
Discover what's making headlines across other trending companies.
Sironax
Aperture Therapeutics
Attentive
Klaviyo
Twilio
Insider One
Zeta Global
Iterable
Braze
Optimove
Bluecore
BlueConic
Amperity
Wero
BLIK
EPI
Swish
Affirm
Brite Payments
TCS
Overview Energy
Adfin
Ineffable Intelligence
Mechanize
Hexatronic
Alimak Group
Lindab Group
NYAB
Noon Energy
Nordan AI
Mips
Vexlum
Asker Healthcare Group
FAKRO